Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive days

Eur J Cancer. 1994;30A(3):417-8. doi: 10.1016/0959-8049(94)90276-3.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Letter

MeSH terms

  • Antimetabolites, Antineoplastic / administration & dosage*
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives*
  • Drug Administration Schedule
  • Female
  • Fever / chemically induced
  • Gemcitabine
  • Humans
  • Male
  • Middle Aged
  • Neoplasms / drug therapy

Substances

  • Antimetabolites, Antineoplastic
  • Deoxycytidine
  • Gemcitabine